Relative Increase in IgG Antibodies to Pseudomonas aeruginosa 60-kDa GroEL in Prediabetic Patients with Cystic Fibrosis

Inhalation of specific anti-Pseudomonas aeruginosa IgY antibodies transiently decreases P. aeruginosa colonization of the airway in mechanically ventilated piglets, Intensive Care Medicine Experimental

Clinical importance of cystic fibrosis-related diabetes - ScienceDirect

Pathogens, Free Full-Text

In Vivo Proteome of Pseudomonas aeruginosa in Airways of Cystic Fibrosis Patients

Frontiers Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies

Pseudomonas aeruginosa aggregation and Psl expression in sputum is associated with antibiotic eradication failure in children with cystic fibrosis

Jornal Brasileiro de Pneumologia - Diabetes mellitus in patients with cystic fibrosis

Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial

Antimicrobial Peptides against Multidrug-Resistant Pseudomonas aeruginosa Biofilm from Cystic Fibrosis Patients

Niels HØIBY, Professor (Full), MD, DMSc, Rigshospitalet, Copenhagen, rigshospitalet, Department of Clinical Microbiology